VEEV · Q3 2026 Earnings

Cautious

Veeva Systems

Reported November 20, 2025

30-second summary

Veeva delivered Q3 FY2026 revenue of $811M (+16% YoY) and non-GAAP EPS of $2.04, beating its own Q3 guide by ~2.3% on revenue and ~4.6% on EPS, and raised FY26 guidance across revenue (+$30M midpoint to $3,166–3,169M), non-GAAP EPS (+$0.15 to $7.93), and non-GAAP operating income (+$29M to ~$1,417M). The substantive change this quarter is Q&A disclosure that six of the original top-20 Vault CRM commits have opted for other solutions — management framed CRM as now only 20% of revenue (down from 25%) with 2030 targets intact, but the bull case has rotated from "consolidation of top-20 biopharma onto Vault CRM" to "R&D Development Cloud + AI carry the load while CRM shrinks." Q4 revenue guide of $807–810M implies a slight sequential decline despite Q3's beat.

Headline numbers

EPS

Q3 FY2026

$2.04

Revenue

Q3 FY2026

$0.81B

+16.0% YoY

Gross margin

Q3 FY2026

75.4%

Operating margin

Q3 FY2026

29.7%

Key financials

Q3 FY2026

Metric	Q3 FY2026	YoY	Q2 FY2026	QoQ
Revenue	$0.81B	+16.0%	$0.79B	+2.8%
EPS	$2.04	—	$1.99	+2.5%
Gross margin	75.4%	—	75.3%	+10bps
Operating margin	29.7%	—	24.8%	+490bps

Guidance

Veeva raised FY2026 guidance across revenue, operating income, and EPS following Q3 beat on all fronts; Q4 guide implies modest sequential softness but maintains strong margin structure.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
Revenue	Q3 FY2026	$790–$793 million	$811.2 million	+$18.2–$21.2 million above guide (top end +2.7%)	Beat
Non-GAAP Operating Income	Q3 FY2026	$348–$350 million	$350+ million	at or slightly above high end of guide	Beat
Non-GAAP EPS	Q3 FY2026	$1.94–$1.95	$2.04	+$0.09–$0.10 above guide (4.6–5.2% above high end)	Beat

New guidance

Metric	Period	Guide	YoY
Revenue	Q4 FY2026	$807–$810 million	—
Non-GAAP EPS	Q4 FY2026	$1.92	—
Non-GAAP Operating Income	Q4 FY2026	about $350 million	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Revenue	FY2026	$3,134–$3,140 million	$3,166–$3,169 million	+$26–$35 million (midpoint +$29.8M or +0.95%)	Raised
Non-GAAP Operating Income	FY2026	about $1,388 million	about $1,417 million	+$29 million (+2.1%)	Raised
Non-GAAP EPS	FY2026	$7.78	$7.93	+$0.15 (+1.9%)	Raised

Segment KPIs

Q3 FY2026

Segment	Q3 FY2026	YoY
Veeva Commercial Solutions	$0.365B	+14.1%
Veeva R&D Solutions	$0.446B	+20.6%
Subscription Services Revenue	$682.5M	—

Other KPIs

Q3 FY2026

Segment	Q3 FY2026
Subscription Services Revenue Growth YoY	17%
Veeva Vault CRM Live Customers	115
Veeva Vault CRM Net New Customers (Q3)	23
Non-GAAP Operating Margin	45.0%
Non-GAAP Net Income per Share	$2.04

Management tone

Narrative arc: Q1 "AI as operating model" → Q2 "IQVIA constraint released, runway clear" → Q3 "AI agents shipping in December; CRM reframed as smaller share of business."

Vault CRM moved from "consolidation thesis" to "defensible 20% of revenue with cross-sell offsets." Two quarters ago management was making the case that all 20 top-20 biopharmas would migrate; last quarter the framing was "7 committed, 2 live, runway clear"; this quarter it is "14 remaining, 400 total customers, CRM is 20% of revenue." Brian Van Wagener's framing in the Barclays exchange — "CRM is 20% of total revenue, down from 25% two years ago, other product areas are growing faster" — is technically reassuring but it is also a soft repositioning. Two years ago Vault CRM was the headline growth catalyst; today it is being framed as the smaller, defensible piece while R&D and AI carry the story. That reframing is consistent with the Q4 guide that does not lean further into pipeline.

AI shifted from "December launch dated" to "December launch shipping, with deep industry-specific agents framed as differentiator." Peter Gassner's Q&A response that customers want "practical, rapidly deployable solutions moving beyond experimentation" — paired with the prepared-remarks line that "the first agents for CRM and commercial content are on track for release in early December" — converts the AI roadmap from forward-looking pitch to imminent product. The customer feedback Gassner cited (compliant free-text capture, safety case processing) is more concrete than Q1's directional 4:1 value framing. But pricing, named early-access customers, and committed pilot bookings remain undisclosed; the December launch is the credibility test.

Development Cloud emerged as the new flagship narrative. Three top-20s selected Veeva Development Cloud as their enterprise standard this quarter — language that was not present in Q1 or Q2 disclosure. Gassner used the Q&A to walk through Development Cloud product-by-product: 20 of 20 on eTMF, zero top-20s on RTSM/ECOA/LIMS, "still early days given 10-15 year system lifecycles." This is the most explicit substitution yet of R&D for Commercial as the long-duration growth engine — and it is being made just as the top-20 Vault CRM story partially breaks.

Competitive posture against Salesforce hardened defensively rather than offensively. Last quarter Gassner characterized the earliest top-20 Salesforce go-live as "end-2026 finishing potentially in 2029" with "low chance" all three commits go live in all regions. This quarter, with six top-20s now confirmed defecting, the framing pivoted to integrated-ecosystem language: "Salesforce has very new CRM product without comprehensive ecosystem... Viva has built industry cloud with mission-critical integrations across multiple product areas." The differentiation argument is intact; the customer scoreboard is worse than it appeared a quarter ago.

Pipeline confidence softened by one click. Q2 framed Q3/Q4 as "closer than 90 days ago, things firming up." This quarter's Q4 guide of $807–810M sits below the Q3 print of $811.2M. Management did not retract the prior commentary, but the implicit message of a sequentially-down guide on a beat-and-raise quarter is that the pipeline is no longer accelerating. For a name where the bull case rests on 16–17% durable growth, that signal warrants attention.

Recurring themes management leaned on this quarter:

Viva AI as strategic growth driverExecution above guidanceBroad-based product innovationMulti-segment strengthIndustry transformation narrative

Risks management surfaced:

Forward-looking statements subject to risks and uncertaintiesActual results may differ materially from expectationsInformation may become inaccurate if call replayed after today

Q&A highlights

Sakat Kalia · Barclays

How should Viva think about the revenue at risk from six top-20 CRM customers opting for other solutions, and what is the timeline for that transition?

Brian stated CRM is 20% of total revenue (down from 25% two years ago) and other product areas are growing faster. No impact expected in 2022, likely nothing material in 2023 either. Long-term, no expected impact on 2030 goals given diverse business with multiple paths to reach targets.

CRM represents 20% of total revenue (down from 25% two years ago)Multi-year migration projects expectedNo revenue impact expected this year or likely next yearStill on track for 2030 goals

Joe Verwink · Baird

With CRM attrition offset by cross-sell opportunities (service center, marketing automation, Viva AI), how should investors think about net revenue impact over five years?

Brian confirmed significant potential in new CRM suite innovations and cross-sell opportunities. Early evidence shows some retained customers already adding adjacent products. Potential to win back some customers. CRM business remains healthy with strong win rates, particularly in smaller customer segments. Peter added that CRM has ~400 total customers, not just top 20, with strong conversion rates among smaller accounts that avoid custom builds.

115 customers live on Vault CRM including some top 20s~400 total CRM customers (distributed base)Early evidence of retained customers adopting additional CRM suite productsStrong win rate and conversion rate, especially in SMB segment

Charles Rhee · TD Cowan

Among top 25 development cloud customers, what is the average number of Viva development cloud products adopted, and what constitutes 'full Viva' environment on R&D side?

Peter clarified that Merck strategic partnership did not mean moving to full Viva everywhere. Development cloud adoption varies by area: ETMF has 20 of top 20; newer areas (RTSM, ECOA, LIMS) still in early stages with few or no top 20 selections. Development cloud adoption still in early days given 10-15 year system lifecycles and continuous new product additions. Manufacturing and LIMS represent significant greenfield opportunities.

ETMF: 20 of top 20 selected VivaRTSM, ECOA, LIMS: No top 20 customers yet selected as enterprise standardLIMS early adopter announced for two manufacturing sites (first top 20)Systems typically stay in place 15 years, limiting replacement frequency

Answers to last quarter's watch list

Nitro and Network revenue or customer disclosure — Not called out on the print or in disclosed Q&A. The "runway is clear" framing from Q2 was not revisited with quantified ramp metrics. Status: Continue monitoring

Top-20 Vault CRM commits beyond 7 — Resolved decisively in the wrong direction. Q&A revealed six top-20 commits have opted for other solutions, leaving 14 remaining — a step backward, not forward, from the 7-committed/2-live baseline last quarter. Management's pivot to "CRM is 20% of revenue, 400 total customers" reframes the metric rather than answering it. Status: Resolved negatively

Commercial services revenue trajectory — Not separately disclosed at the segment-services level in the available print materials. Total Commercial Solutions revenue grew 14.1%, broadly consistent with Q2's trajectory, but the standalone services line wasn't called out. Status: Continue monitoring

Veeva AI December launch deliverables — Partially resolved. First agents for CRM and commercial content confirmed on track for early-December release. Pricing, named early-access customers, and committed pilot bookings still undisclosed; the December launch itself is now the gating disclosure event. Status: Continue monitoring

Horizontal CRM first customer — Not addressed in the disclosed materials. Gassner's Q1 commitment to "first customers by year-end" now has one quarter to materialize. Status: Not resolved

Compass prescriber product — Not addressed in the disclosed materials. The slower-ramp flag from Q2 was not revisited. Status: Continue monitoring

What to watch into next quarter

Whether any of the six defecting top-20 CRM customers are won back, or whether the count drops further. Management committed to "potential to win back some customers" — a Q4 print with 14 holding steady is the floor; anything below 14 is a thesis-breaker; a public win-back is the upside scenario.

Veeva AI December launch — pricing model, named early-access customers, and any disclosed bookings. The December release is now imminent; absence of named customers or pricing detail on the Q4 call would be a credibility issue given the runway management has set.

Q4 revenue versus the $807–810M guide. A beat in line with Q2 and Q3's ~$18–21M cadence puts FY26 above $3.18B; a print below $810M with no special items would suggest the sequentially-down guide reflected genuine pipeline deceleration rather than conservatism.

Development Cloud top-20 enterprise standard adds beyond the three named this quarter. Three top-20s selected Development Cloud as enterprise standard in Q3; sustained 2–3 per quarter validates R&D as the growth substitute for Commercial; fewer would suggest the three were lumpy.

Horizontal CRM first customer announcement. Gassner's year-end commitment from Q1 expires with the Q4 print; silence at that point makes this a multi-quarter credibility item.

Any FY27 directional commentary on the Q4 call. With CRM defection now public and the Q4 guide softer than expected, the first hint of FY27 framing — particularly the revenue growth bracket — will set the stock's near-term anchor more than the FY26 print itself.

Sources

Veeva Systems Q3 FY2026 press release, SEC filing (veev-20251031q326xex991.htm), November 20, 2025.
Veeva Systems Q3 FY2026 earnings call Q&A commentary (analyst exchanges with Sakat Kalia/Barclays, Joe Verwink/Baird, Charles Rhee/TD Cowen).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.